home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Accera, Inc.

SHARESHARESHARE
Accera is a clinical stage biotechnology company that develops therapies for central nervous system disorders. Accera’s proprietary scientific platform addresses numerous unmet needs in brain health including Alzheimer’s disease. We believe our development-stage proprietary compounds have innovative mechanisms of action that have the potential to positively impact patients’ lives as well as those of their families. Our executive management team includes globally recognized specialists in central nervous system diseases who together leverage the latest scientific knowledge and understanding of neurological disorders.
SHARESHARESHARE

RELATED NEWS


The European Commission has approved Alexion Pharmaceuticals' Ultomiris (ravulizumab) for the treatment of some adults with the ultra-rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH). The decision allows use of the drug – the first and only long-acting C5 complement inhibitor administered every eight weeks – in patients with haemolysis with clinical symptoms indicative of high disease activity, and also for those who are clinically stable after having been treated w...

READ MORE

AstraZeneca’s Fasenra is already pressuring GlaxoSmithKline's Nucala in severe eosinophilic asthma, and new data could help set up a showdown between the two in another indication. By week 12 of a phase 2 study in hypereosinophilic syndrome (HES), Fasenra cut patients' blood eosinophil counts by at least half, AstraZeneca showed with results published Thursday. Only 30% of patients taking placebo reached that mark. In patients with biopsies taken, results showed a “near-compl...
FIERCEPHARMA
READ MORE

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...

READ MORE

The research report on “Global Aseptic Packaging for the Pharmaceutical Market” serves in-depth analysis on latest and upcoming market scenario of Aseptic Packaging for the Pharmaceutical in the appraisal period, 2020-2025. The report survey Aseptic Packaging for the Pharmaceutical market growth past, sales channel, players profiled in Aseptic Packaging for the Pharmaceutical industry, product type and application market share and Aseptic Packaging for the Pharmaceutical regional sco...
FASHION TRENDS NOW
READ MORE

NICE has issued draft guidance which rejects Ipsen’s Cabometyx for NHS use in previously treated advanced renal cell carcinoma (RCC). Cabometyx (cabozantinib), is an important new treatment for the company, and its pivotal trials showed the drug can extend overall survival in previously treated patients, the first such drug to show these benefits....

READ MORE

Oligonucleotides are single-stranded and short RNA or DNA molecule that have a wide range of applications in research forensics and genetic testing. Oligonucleotides are made by chemical synthesis in the laboratory. Oligonucleotide synthesis has its application in therapeutics, human identification test, cell cultures, library preparations, human identity testing. Oligonucleotides also have its application in nucleic acid array based technology, diagnostics, genetic engineering, next-generation ...
MEDGADGET.COM
READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...